Nauzene Kids is ready for stomach flu season
S.C. Bausch + Lomb plant manufactures 4 billionth bottle
LAVAL, Quebec — Valeant Pharmaceuticals recently announced that Bausch and Lomb’s Greenville Solutions Plant in Greenville, S.C. has manufactured its four billionth bottle of eye care products. The company commemorated the milestone with a tour of the facility attended by Valeant chairman and CEO J. Michael Pearson and elected officials, local business leaders and plant employees, and bottles in the batch containing the four billionth one featured a commemorative label.
“Reaching this incredible milestone at Bausch + Lomb's Greenville Solutions Plant demonstrates the enormous impact that the facility has had across the globe,” Pearson said. “Whether it's one of the hundreds of employees creating our top-of-the-line products, or a consumer who has bought one of our four billion bottles manufactured at this facility for his or her lens care needs, the work that is done here is essential to peoples' lives. We are incredibly proud of the employees in Greenville, who reflect the very best of Valeant Pharmaceuticals.”
Valeant and Bausch + Lomb also announced that it would be investing about $25 million in a state-of-art integrated line that would add 30 new jobs and 40 million units of capacity. Valeant will be investing $150 million in the next five years with the hope of creating 150 to 200 new jobs in that time.
“Longstanding businesses in our community have provided valuable contributions to our thriving workforce,” Sen. Tim Scott, R-S.C., said. “Being able to celebrate major production milestones underscores the dedication of these businesses in our state, and reinforces South Carolina's role as the center of our nation's manufacturing renaissance.”
International Osteoporosis Foundation finds almost 90% people are calcium deficient
- The average calcium intake was 594 mg per day. Even if an additional 300 mg is added to this total to account for any calcium obtained through sources not included in the calculator, the users would still be deficient;
- Men and women had almost equal percentages of insufficiency (89% vs. 90%, respectively), with no significant difference across the age groups;11% achieved sufficient calcium intake levels; and
- 29% of respondents had previously been diagnosed with osteoporosis or osteopenia.